Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Publication
, Journal Article
Storb, R; Pepe, M; Deeg, HJ; Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Doney, K; Hansen, J
Published in: Blood
July 15, 1992
Duke Scholars
Published In
Blood
ISSN
0006-4971
Publication Date
July 15, 1992
Volume
80
Issue
2
Start / End Page
560 / 561
Location
United States
Related Subject Headings
- Time Factors
- Methotrexate
- Leukemia, Myeloid, Acute
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia
- Immunology
- Humans
- Histocompatibility Testing
- HLA Antigens
- Graft vs Host Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Storb, R., Pepe, M., Deeg, H. J., Anasetti, C., Appelbaum, F. R., Bensinger, W., … Hansen, J. (1992). Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood, 80(2), 560–561.
Storb, R., M. Pepe, H. J. Deeg, C. Anasetti, F. R. Appelbaum, W. Bensinger, C. D. Buckner, R. A. Cliff, K. Doney, and J. Hansen. “Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.” Blood 80, no. 2 (July 15, 1992): 560–61.
Storb R, Pepe M, Deeg HJ, Anasetti C, Appelbaum FR, Bensinger W, et al. Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood. 1992 Jul 15;80(2):560–1.
Storb, R., et al. “Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.” Blood, vol. 80, no. 2, July 1992, pp. 560–61.
Storb R, Pepe M, Deeg HJ, Anasetti C, Appelbaum FR, Bensinger W, Buckner CD, Cliff RA, Doney K, Hansen J. Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood. 1992 Jul 15;80(2):560–561.
Published In
Blood
ISSN
0006-4971
Publication Date
July 15, 1992
Volume
80
Issue
2
Start / End Page
560 / 561
Location
United States
Related Subject Headings
- Time Factors
- Methotrexate
- Leukemia, Myeloid, Acute
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia
- Immunology
- Humans
- Histocompatibility Testing
- HLA Antigens
- Graft vs Host Disease